Southpaw:
I really liked your QIS writeup. Do you have something similar for QHR. At first glance, it appears to be a leading niche SAAS software company trading at 2x recurring revenue with room for growth, both from greenfield opportunities and other EMR software providers.
One question I do have is if EMR software is very sticky, why is QHR able to obtain 1/3 of new sales are from competing EMR providers? Do they have a superior product? Lower cost to the user?
Also, do you have a sense of the returns on capital the company has been able to achieve on its acquisitions of competing EMR providers? The recent Jonoke transaction, for example, appears to have given QHR access to $1 million in recurring revenue for almost nothing (I understand that not all of the Jonoke users will transition to QHR).